The majority of cancer-related HTRA1 research hypothesized it as a tumor suppressor, such as, ovarian cancer, endometrial cancer, hepatocellular carcinoma, and melanoma [20–23]. This evidence concerns the gene HTRA1 and ovarian carcinoma.